Newspaper had reported that government was expecting European regulator’s assessment to show that vaccine was only 8% effective among over-65
The German government has challenged reports of a lower-than-expected efficacy rate of the AstraZeneca vaccine for older people, while reiterating concerns about the British-Swedish pharmaceutical giant’s data reporting.
An article in German business daily Handelsblatt had reported that the German government was expecting the European Medical Agency’s (EMA) assessment to show the AstraZeneca vaccine to be only 8% effective among the over-65s, describing it a “setback for Berlin’s vaccination strategy”.
